array:21 [
  "pii" => "X0211699513052912"
  "issn" => "02116995"
  "doi" => "10.3265/Nefrologia.pre2013.Apr.11800"
  "estado" => "S300"
  "fechaPublicacion" => "2013-07-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2013;33:478-85"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 7199
    "formatos" => array:3 [
      "EPUB" => 293
      "HTML" => 6228
      "PDF" => 678
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:17 [
      "pii" => "X201325141305291X"
      "issn" => "20132514"
      "doi" => "10.3265/Nefrologia.pre2013.Apr.11800"
      "estado" => "S300"
      "fechaPublicacion" => "2013-07-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia (English Version). 2013;33:478-85"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 5329
        "formatos" => array:3 [
          "EPUB" => 319
          "HTML" => 4271
          "PDF" => 739
        ]
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "titulo" => "The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "478"
            "paginaFinal" => "485"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig1"
            "etiqueta" => "Tab.  1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "copyright" => "Elsevier España"
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "11800_16025_42020_en_t111800_03_maquetacin_1.jpg"
                "Alto" => 673
                "Ancho" => 2181
                "Tamanyo" => 274482
              ]
            ]
            "descripcion" => array:1 [
              "en" => "Main characteristics of the patients"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Vi¿nja Le¿aić, Nenad Petković, Ivko Marić, Branislava Miljković, Katarina Vučićević, Sanja Simić-Ogrizović, Vesna Pejovic, Ljubica Djukanović"
            "autores" => array:8 [
              0 => array:2 [
                "nombre" => "Vi¿nja"
                "apellidos" => "Le¿aić"
              ]
              1 => array:2 [
                "nombre" => "Nenad"
                "apellidos" => "Petković"
              ]
              2 => array:2 [
                "nombre" => "Ivko"
                "apellidos" => "Marić"
              ]
              3 => array:2 [
                "nombre" => "Branislava"
                "apellidos" => "Miljković"
              ]
              4 => array:2 [
                "nombre" => "Katarina"
                "apellidos" => "Vučićević"
              ]
              5 => array:2 [
                "nombre" => "Sanja"
                "apellidos" => "Simić-Ogrizović"
              ]
              6 => array:2 [
                "nombre" => "Vesna"
                "apellidos" => "Pejovic"
              ]
              7 => array:2 [
                "nombre" => "Ljubica"
                "apellidos" => "Djukanović"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "X0211699513052912"
          "doi" => "10.3265/Nefrologia.pre2013.Apr.11800"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052912?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141305291X?idApp=UINPBA000064"
      "url" => "/20132514/0000003300000004/v0_201502091629/X201325141305291X/v0_201502091630/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X0211699513052904"
    "issn" => "02116995"
    "doi" => "10.3265/Nefrologia.pre2013.Feb.11872"
    "estado" => "S300"
    "fechaPublicacion" => "2013-07-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2013;33:486-94"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 14276
      "formatos" => array:3 [
        "EPUB" => 292
        "HTML" => 13342
        "PDF" => 642
      ]
    ]
    "es" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "Concentraciones más elevadas de fósforo sérico en pacientes con enfermedad renal crónica avanzada tratados con diuréticos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "486"
          "paginaFinal" => "494"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Increased serum phosphate concentrations in patients with advanced chronic kidney disease treated with diuretics"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "11872_19904_39928_es_11872_t1_copy1.jpg"
              "Alto" => 387
              "Ancho" => 600
              "Tamanyo" => 219638
            ]
          ]
          "descripcion" => array:1 [
            "es" => "Características demográficas, clínicas y bioquímicas del grupo de estudio total y de los subgrupos de acuerdo con el tratamiento diurético o no"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Francisco Caravaca, Guadalupe García-Pino, Rocío Martínez-Gallardo, Flavio Ferreira-Morong, Enrique Luna, Raúl Alvarado, Enrique Ruiz-Donoso, Edgar Chavez, Edgar Chávez"
          "autores" => array:9 [
            0 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "Caravaca"
            ]
            1 => array:2 [
              "nombre" => "Guadalupe"
              "apellidos" => "García-Pino"
            ]
            2 => array:2 [
              "nombre" => "Rocío"
              "apellidos" => "Martínez-Gallardo"
            ]
            3 => array:2 [
              "nombre" => "Flavio"
              "apellidos" => "Ferreira-Morong"
            ]
            4 => array:2 [
              "nombre" => "Enrique"
              "apellidos" => "Luna"
            ]
            5 => array:2 [
              "nombre" => "Raúl"
              "apellidos" => "Alvarado"
            ]
            6 => array:2 [
              "nombre" => "Enrique"
              "apellidos" => "Ruiz-Donoso"
            ]
            7 => array:2 [
              "nombre" => "Edgar"
              "apellidos" => "Chavez"
            ]
            8 => array:2 [
              "nombre" => "Edgar"
              "apellidos" => "Chávez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "X2013251413052901"
        "doi" => "10.3265/Nefrologia.pre2013.Feb.11872"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413052901?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052904?idApp=UINPBA000064"
    "url" => "/02116995/0000003300000004/v0_201502091404/X0211699513052904/v0_201502091404/es/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X0211699513052920"
    "issn" => "02116995"
    "doi" => "10.3265/Nefrologia.pre2013.Feb.11725"
    "estado" => "S300"
    "fechaPublicacion" => "2013-07-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2013;33:470-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6663
      "formatos" => array:3 [
        "EPUB" => 280
        "HTML" => 5678
        "PDF" => 705
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Costos y resultados del tratamiento endovascular de las trombosis en las fístulas autólogas para hemodiálisis"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "470"
          "paginaFinal" => "477"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Costs and outcomes of endovascular treatment of thrombosed dialysis autogenous fistulae"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Luis Coentrao"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Luis"
              "apellidos" => "Coentrao"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "X2013251413052928"
        "doi" => "10.3265/Nefrologia.pre2013.Feb.11725"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413052928?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052920?idApp=UINPBA000064"
    "url" => "/02116995/0000003300000004/v0_201502091404/X0211699513052920/v0_201502091404/es/main.assets"
  ]
  "es" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "478"
        "paginaFinal" => "485"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Vi¿nja Le¿aić, Nenad Petković, Ivko Marić, Branislava Miljković, Katarina Vučićević, Sanja Simić-Ogrizović, Vesna Pejovic, Ljubica Djukanović"
        "autores" => array:8 [
          0 => array:4 [
            "nombre" => "Vi¿nja"
            "apellidos" => "Le¿aić"
            "email" => array:1 [
              0 => "visnjalezaic@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Nenad"
            "apellidos" => "Petkovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Ivko"
            "apellidos" => "Mari&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Branislava"
            "apellidos" => "Miljkovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Katarina"
            "apellidos" => "Vu&#269;i&#263;evi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Sanja"
            "apellidos" => "Simi&#263;-Ogrizovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Vesna"
            "apellidos" => "Pejovic"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Ljubica"
            "apellidos" => "Djukanovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "affe"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => " University of Belgrade, Medical Faculty, Serbia, b Clinical Centre of Serbia, Department of Nephrology, Belgrade,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => " FMC Center ¿amac, BH, ¿amac,  BH, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => " Special Hospital for Endemic Nephropathy, Lazarevac,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
          3 => array:3 [
            "entidad" => " Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">d</span>"
            "identificador" => "affd"
          ]
          4 => array:3 [
            "entidad" => " Serbian Medical Society, Academy of Medical Science, Belgrade,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">e</span>"
            "identificador" => "affe"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients"
      ]
    ]
    "pdfFichero" => "P1-E557-S4299-A11800.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec434053"
          "palabras" => array:1 [
            0 => "Farmacocin&#233;tica"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec434055"
          "palabras" => array:1 [
            0 => "Eritropoyetina recombinante humana"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec434057"
          "palabras" => array:1 [
            0 => "Nefropat&#237;a end&#233;mica de los Balcanes"
          ]
        ]
      ]
      "en" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec434054"
          "palabras" => array:1 [
            0 => "Pharmacokinetics"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec434056"
          "palabras" => array:1 [
            0 => "Human recombinant erythropoietin"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec434058"
          "palabras" => array:1 [
            0 => "Balkan endemic nephropathy"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Antecedentes&#58;</span>&#160;Los pacientes con nefropat&#237;a end&#233;mica de los Balcanes &#40;NEB&#41; en hemodi&#225;lisis necesitan una dosis m&#225;s elevada de eritropoyetina recombinante humana que los pacientes con otras enfermedades renales para poder mantener el nivel de hemoglobina deseado&#46; <span class="elsevierStyleBold">Objetivos&#58;</span><span class="elsevierStyleBold"> </span>Comparar la farmacocin&#233;tica de la eritropoyetina beta administrada subcut&#225;neamente a pacientes en hemodi&#225;lisis con NEB u otras enfermedades renales&#46;<span class="elsevierStyleBold">&#160;</span><span class="elsevierStyleBold">M&#233;todos&#58;</span>&#160;A 10 pacientes hemodializados con NEB y 14 pacientes hemodializados con otras enfermedades renales se les administr&#243; subcut&#225;neamente eritropoyetina &#40;EPO&#41; recombinante humana &#40;75&#160;U&#47;kg&#41;&#46; El nivel de EPO en plasma previo a la dosis se sustrajo de todos los niveles que se obtuvieron tras administrarla&#46; Los par&#225;metros farmacocin&#233;ticos relevantes se calcularon tras el an&#225;lisis farmacocin&#233;tico no compartimental con ayuda de la aplicaci&#243;n Kinetica &#40;Thermo Scientific&#44; versi&#243;n 5&#46;0&#41;&#46;<span class="elsevierStyleBold"> </span><span class="elsevierStyleBold">Resultados&#58;</span> Aunque la concentraci&#243;n basal de EPO en el plasma era similar en pacientes con NEB &#40;20&#44;1&#160;&#177;&#160;10&#44;3&#160;U&#47;l&#41; y en pacientes con otras enfermedades renales &#40;15&#44;1&#160;&#177;&#160;8&#44;1&#160;U&#47;l&#59; p&#160;&#61;&#160;0&#44;1964&#41;&#44; se apreciaron diferencias significativas entre los grupos con respecto a la constante de eliminaci&#243;n &#40;0&#44;016&#160;&#177;&#160;0&#44;006 vs&#46; 0&#44;026&#160;&#177;&#160;0&#44;011&#160;h<span class="elsevierStyleSup">-1</span>&#59; p&#160;&#61;&#160;0&#44;020&#41; y a la semivida de eliminaci&#243;n &#40;50&#44;24&#160;&#177;&#160;19&#44;12 vs&#46; 33&#44;79&#160;&#177;&#160;18&#44;91&#160;h&#44; p&#160;&#61;&#160;0&#44;048&#41;&#46; Estas diferencias resultaron igualmente significativas tras ajustar los valores en funci&#243;n de las caracter&#237;sticas de los pacientes &#40;edad&#44; sexo&#44; duraci&#243;n de la hemodi&#225;lisis&#44; ferritina&#44; hormona paratiroidea y uso de inhibidores de la enzima de conversi&#243;n de la angiotensina&#41;&#46; No obstante&#44; no se observaron diferencias significativas entre los grupos en los siguientes par&#225;metros ni antes ni despu&#233;s de efectuar los ajustes pertinentes&#58; concentraci&#243;n m&#225;xima de EPO&#44; tiempo en alcanzar la concentraci&#243;n m&#225;xima de EPO&#44; &#225;rea bajo la curva extrapolada al infinito a partir de la administraci&#243;n de la dosis&#44; aclaramiento y tiempo medio de permanencia de la EPO&#46;<span class="elsevierStyleBold">&#160;</span><span class="elsevierStyleBold">Conclusi&#243;n&#58;</span>&#160;El an&#225;lisis farmacocin&#233;tico de la eritropoyetina beta revel&#243; que la semivida de eliminaci&#243;n era significativamente m&#225;s larga en los pacientes con NEB&#44; hallazgo que debe ser confirmado en un estudio bien controlado con una muestra m&#225;s grande&#46;</p>"
      ]
      "en" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Background&#58;</span> Balkan endemic nephropathy &#40;BEN&#41; hemodialysis patients require a higher dose of recombinant human erythropoietin for maintaining target hemoglobin level than patients with other kidney diseases&#46;&#160;<span class="elsevierStyleBold">Objectives&#58; </span>Comparison of the pharmacokinetics of beta-erythropoietin given subcutaneously to hemodialysis patients with BEN or other kidney diseases &#40;non-BEN&#41;&#46;<span class="elsevierStyleBold"> Methods&#58;</span> Recombinant human erythropoietin &#40;75U&#47;kg&#41; was administered subcutaneously to 10 BEN and 14 non-BEN hemodialysis patients&#46; The predose plasma level of erythropoietin &#40;Epo&#41; was subtracted from all postdose levels&#46; The relevant pharmacokinetic parameters were calculated after noncompartmental pharmacokinetic analysis using Kinetica software &#40;Thermo Scientific&#44; ver&#46;5&#46;0&#41;&#46;<span class="elsevierStyleBold"> Results&#58;</span> Although basal plasma Epo concentration was similar in BEN &#40;20&#46;1&#177;10&#46;3U&#47;L&#41; and non-BEN &#40;15&#46;1&#177;8&#46;1U&#47;L&#59; p&#61;&#46;1964&#41; patients&#44; there were significant differences between the groups for elimination rate constant &#40;0&#46;016&#177;0&#46;006 vs 0&#46;026&#177;0&#46;011 hr<span class="elsevierStyleSup">-1</span>&#59; p&#61;&#46;020&#41; and elimination half-life &#40;50&#46;24&#177;19&#46;12 vs 33&#46;79&#177;18&#46;91 hr&#44; p&#61;&#46;048&#41;&#46; These differences remained significant after adjustment for patient characteristics &#40;age&#44; sex&#44; hemodialysis duration&#44; ferritin&#44; PTH and ACEI use&#41;&#46; No significant differences between groups were found in maximal Epo concentration&#44; time to maximum Epo concentration&#44; area under the curve from time of dosing extrapolated to infinity&#44; clearance&#44; mean residence time of Epo between groups both before and after adjustment&#46;<span class="elsevierStyleBold"> Conclusion&#58;</span> Pharmacokinetic analysis of beta-erythropoietin detected a significantly longer elimination half-life in BEN than in non BEN patients&#46; This finding needs to be confirmed in a well-controlled study with a larger sample size&#46;</p>"
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02116995/0000003300000004/v0_201502091404/X0211699513052912/v0_201502091404/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35343"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Especiales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003300000004/v0_201502091404/X0211699513052912/v0_201502091404/es/P1-E557-S4299-A11800.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052912?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes
The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients
Vi¿nja Le¿aića, Nenad Petkovićb, Ivko Marićc, Branislava Miljkovićd, Katarina Vučićevićd, Sanja Simić-Ogrizovića, Vesna Pejovicc, Ljubica Djukanoviće
a University of Belgrade, Medical Faculty, Serbia, b Clinical Centre of Serbia, Department of Nephrology, Belgrade, Serbia,
b FMC Center ¿amac, BH, ¿amac, BH,
c Special Hospital for Endemic Nephropathy, Lazarevac, Serbia,
d Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia,
e Serbian Medical Society, Academy of Medical Science, Belgrade, Serbia,
Leído
15111
Veces
se ha leído el artículo
3385
Total PDF
11726
Total HTML
Compartir estadísticas
 array:21 [
  "pii" => "X0211699513052912"
  "issn" => "02116995"
  "doi" => "10.3265/Nefrologia.pre2013.Apr.11800"
  "estado" => "S300"
  "fechaPublicacion" => "2013-07-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2013;33:478-85"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 7199
    "formatos" => array:3 [
      "EPUB" => 293
      "HTML" => 6228
      "PDF" => 678
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:17 [
      "pii" => "X201325141305291X"
      "issn" => "20132514"
      "doi" => "10.3265/Nefrologia.pre2013.Apr.11800"
      "estado" => "S300"
      "fechaPublicacion" => "2013-07-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia &#40;English Version&#41;. 2013;33:478-85"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 5329
        "formatos" => array:3 [
          "EPUB" => 319
          "HTML" => 4271
          "PDF" => 739
        ]
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "titulo" => "The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "478"
            "paginaFinal" => "485"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "La farmacocin&#233;tica de la eritropoyetina recombinante humana en pacientes con nefropat&#237;a end&#233;mica de los Balcanes"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig1"
            "etiqueta" => "Tab.  1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "copyright" => "Elsevier Espa&#241;a"
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "11800_16025_42020_en_t111800_03_maquetacin_1.jpg"
                "Alto" => 673
                "Ancho" => 2181
                "Tamanyo" => 274482
              ]
            ]
            "descripcion" => array:1 [
              "en" => "Main characteristics of the patients"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Vi&#191;nja Le&#191;ai&#263;, Nenad Petkovi&#263;, Ivko Mari&#263;, Branislava Miljkovi&#263;, Katarina Vu&#269;i&#263;evi&#263;, Sanja Simi&#263;-Ogrizovi&#263;, Vesna Pejovic, Ljubica Djukanovi&#263;"
            "autores" => array:8 [
              0 => array:2 [
                "nombre" => "Vi&#191;nja"
                "apellidos" => "Le&#191;ai&#263;"
              ]
              1 => array:2 [
                "nombre" => "Nenad"
                "apellidos" => "Petkovi&#263;"
              ]
              2 => array:2 [
                "nombre" => "Ivko"
                "apellidos" => "Mari&#263;"
              ]
              3 => array:2 [
                "nombre" => "Branislava"
                "apellidos" => "Miljkovi&#263;"
              ]
              4 => array:2 [
                "nombre" => "Katarina"
                "apellidos" => "Vu&#269;i&#263;evi&#263;"
              ]
              5 => array:2 [
                "nombre" => "Sanja"
                "apellidos" => "Simi&#263;-Ogrizovi&#263;"
              ]
              6 => array:2 [
                "nombre" => "Vesna"
                "apellidos" => "Pejovic"
              ]
              7 => array:2 [
                "nombre" => "Ljubica"
                "apellidos" => "Djukanovi&#263;"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "X0211699513052912"
          "doi" => "10.3265/Nefrologia.pre2013.Apr.11800"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052912?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141305291X?idApp=UINPBA000064"
      "url" => "/20132514/0000003300000004/v0_201502091629/X201325141305291X/v0_201502091630/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X0211699513052904"
    "issn" => "02116995"
    "doi" => "10.3265/Nefrologia.pre2013.Feb.11872"
    "estado" => "S300"
    "fechaPublicacion" => "2013-07-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2013;33:486-94"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 14276
      "formatos" => array:3 [
        "EPUB" => 292
        "HTML" => 13342
        "PDF" => 642
      ]
    ]
    "es" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "Concentraciones m&#225;s elevadas de f&#243;sforo s&#233;rico en pacientes con enfermedad renal cr&#243;nica avanzada tratados con diur&#233;ticos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "486"
          "paginaFinal" => "494"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Increased serum phosphate concentrations in patients with advanced chronic kidney disease treated with diuretics"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "11872_19904_39928_es_11872_t1_copy1.jpg"
              "Alto" => 387
              "Ancho" => 600
              "Tamanyo" => 219638
            ]
          ]
          "descripcion" => array:1 [
            "es" => "Caracter&#237;sticas demogr&#225;ficas&#44; cl&#237;nicas y bioqu&#237;micas del grupo de estudio total y de los subgrupos de acuerdo con el tratamiento diur&#233;tico o no"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Francisco Caravaca, Guadalupe Garc&#237;a-Pino, Roc&#237;o Mart&#237;nez-Gallardo, Flavio Ferreira-Morong, Enrique Luna, Ra&#250;l Alvarado, Enrique Ruiz-Donoso, Edgar Chavez, Edgar Ch&#225;vez"
          "autores" => array:9 [
            0 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "Caravaca"
            ]
            1 => array:2 [
              "nombre" => "Guadalupe"
              "apellidos" => "Garc&#237;a-Pino"
            ]
            2 => array:2 [
              "nombre" => "Roc&#237;o"
              "apellidos" => "Mart&#237;nez-Gallardo"
            ]
            3 => array:2 [
              "nombre" => "Flavio"
              "apellidos" => "Ferreira-Morong"
            ]
            4 => array:2 [
              "nombre" => "Enrique"
              "apellidos" => "Luna"
            ]
            5 => array:2 [
              "nombre" => "Ra&#250;l"
              "apellidos" => "Alvarado"
            ]
            6 => array:2 [
              "nombre" => "Enrique"
              "apellidos" => "Ruiz-Donoso"
            ]
            7 => array:2 [
              "nombre" => "Edgar"
              "apellidos" => "Chavez"
            ]
            8 => array:2 [
              "nombre" => "Edgar"
              "apellidos" => "Ch&#225;vez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "X2013251413052901"
        "doi" => "10.3265/Nefrologia.pre2013.Feb.11872"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413052901?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052904?idApp=UINPBA000064"
    "url" => "/02116995/0000003300000004/v0_201502091404/X0211699513052904/v0_201502091404/es/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X0211699513052920"
    "issn" => "02116995"
    "doi" => "10.3265/Nefrologia.pre2013.Feb.11725"
    "estado" => "S300"
    "fechaPublicacion" => "2013-07-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2013;33:470-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6663
      "formatos" => array:3 [
        "EPUB" => 280
        "HTML" => 5678
        "PDF" => 705
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Costos y resultados del tratamiento endovascular de las trombosis en las f&#237;stulas aut&#243;logas para hemodi&#225;lisis"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "470"
          "paginaFinal" => "477"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Costs and outcomes of endovascular treatment of thrombosed dialysis autogenous fistulae"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Luis Coentrao"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Luis"
              "apellidos" => "Coentrao"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "X2013251413052928"
        "doi" => "10.3265/Nefrologia.pre2013.Feb.11725"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413052928?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052920?idApp=UINPBA000064"
    "url" => "/02116995/0000003300000004/v0_201502091404/X0211699513052920/v0_201502091404/es/main.assets"
  ]
  "es" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "La farmacocin&#233;tica de la eritropoyetina recombinante humana en pacientes con nefropat&#237;a end&#233;mica de los Balcanes"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "478"
        "paginaFinal" => "485"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Vi&#191;nja Le&#191;ai&#263;, Nenad Petkovi&#263;, Ivko Mari&#263;, Branislava Miljkovi&#263;, Katarina Vu&#269;i&#263;evi&#263;, Sanja Simi&#263;-Ogrizovi&#263;, Vesna Pejovic, Ljubica Djukanovi&#263;"
        "autores" => array:8 [
          0 => array:4 [
            "nombre" => "Vi&#191;nja"
            "apellidos" => "Le&#191;ai&#263;"
            "email" => array:1 [
              0 => "visnjalezaic&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Nenad"
            "apellidos" => "Petkovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Ivko"
            "apellidos" => "Mari&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Branislava"
            "apellidos" => "Miljkovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Katarina"
            "apellidos" => "Vu&#269;i&#263;evi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Sanja"
            "apellidos" => "Simi&#263;-Ogrizovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Vesna"
            "apellidos" => "Pejovic"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Ljubica"
            "apellidos" => "Djukanovi&#263;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "affe"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => " University of Belgrade, Medical Faculty, Serbia, b Clinical Centre of Serbia, Department of Nephrology, Belgrade,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => " FMC Center ¿amac, BH, ¿amac,  BH, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => " Special Hospital for Endemic Nephropathy, Lazarevac,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
          3 => array:3 [
            "entidad" => " Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">d</span>"
            "identificador" => "affd"
          ]
          4 => array:3 [
            "entidad" => " Serbian Medical Society, Academy of Medical Science, Belgrade,  Serbia, "
            "etiqueta" => "<span class="elsevierStyleSup">e</span>"
            "identificador" => "affe"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients"
      ]
    ]
    "pdfFichero" => "P1-E557-S4299-A11800.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec434053"
          "palabras" => array:1 [
            0 => "Farmacocin&#233;tica"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec434055"
          "palabras" => array:1 [
            0 => "Eritropoyetina recombinante humana"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec434057"
          "palabras" => array:1 [
            0 => "Nefropat&#237;a end&#233;mica de los Balcanes"
          ]
        ]
      ]
      "en" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec434054"
          "palabras" => array:1 [
            0 => "Pharmacokinetics"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec434056"
          "palabras" => array:1 [
            0 => "Human recombinant erythropoietin"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec434058"
          "palabras" => array:1 [
            0 => "Balkan endemic nephropathy"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Antecedentes&#58;</span>&#160;Los pacientes con nefropat&#237;a end&#233;mica de los Balcanes &#40;NEB&#41; en hemodi&#225;lisis necesitan una dosis m&#225;s elevada de eritropoyetina recombinante humana que los pacientes con otras enfermedades renales para poder mantener el nivel de hemoglobina deseado&#46; <span class="elsevierStyleBold">Objetivos&#58;</span><span class="elsevierStyleBold"> </span>Comparar la farmacocin&#233;tica de la eritropoyetina beta administrada subcut&#225;neamente a pacientes en hemodi&#225;lisis con NEB u otras enfermedades renales&#46;<span class="elsevierStyleBold">&#160;</span><span class="elsevierStyleBold">M&#233;todos&#58;</span>&#160;A 10 pacientes hemodializados con NEB y 14 pacientes hemodializados con otras enfermedades renales se les administr&#243; subcut&#225;neamente eritropoyetina &#40;EPO&#41; recombinante humana &#40;75&#160;U&#47;kg&#41;&#46; El nivel de EPO en plasma previo a la dosis se sustrajo de todos los niveles que se obtuvieron tras administrarla&#46; Los par&#225;metros farmacocin&#233;ticos relevantes se calcularon tras el an&#225;lisis farmacocin&#233;tico no compartimental con ayuda de la aplicaci&#243;n Kinetica &#40;Thermo Scientific&#44; versi&#243;n 5&#46;0&#41;&#46;<span class="elsevierStyleBold"> </span><span class="elsevierStyleBold">Resultados&#58;</span> Aunque la concentraci&#243;n basal de EPO en el plasma era similar en pacientes con NEB &#40;20&#44;1&#160;&#177;&#160;10&#44;3&#160;U&#47;l&#41; y en pacientes con otras enfermedades renales &#40;15&#44;1&#160;&#177;&#160;8&#44;1&#160;U&#47;l&#59; p&#160;&#61;&#160;0&#44;1964&#41;&#44; se apreciaron diferencias significativas entre los grupos con respecto a la constante de eliminaci&#243;n &#40;0&#44;016&#160;&#177;&#160;0&#44;006 vs&#46; 0&#44;026&#160;&#177;&#160;0&#44;011&#160;h<span class="elsevierStyleSup">-1</span>&#59; p&#160;&#61;&#160;0&#44;020&#41; y a la semivida de eliminaci&#243;n &#40;50&#44;24&#160;&#177;&#160;19&#44;12 vs&#46; 33&#44;79&#160;&#177;&#160;18&#44;91&#160;h&#44; p&#160;&#61;&#160;0&#44;048&#41;&#46; Estas diferencias resultaron igualmente significativas tras ajustar los valores en funci&#243;n de las caracter&#237;sticas de los pacientes &#40;edad&#44; sexo&#44; duraci&#243;n de la hemodi&#225;lisis&#44; ferritina&#44; hormona paratiroidea y uso de inhibidores de la enzima de conversi&#243;n de la angiotensina&#41;&#46; No obstante&#44; no se observaron diferencias significativas entre los grupos en los siguientes par&#225;metros ni antes ni despu&#233;s de efectuar los ajustes pertinentes&#58; concentraci&#243;n m&#225;xima de EPO&#44; tiempo en alcanzar la concentraci&#243;n m&#225;xima de EPO&#44; &#225;rea bajo la curva extrapolada al infinito a partir de la administraci&#243;n de la dosis&#44; aclaramiento y tiempo medio de permanencia de la EPO&#46;<span class="elsevierStyleBold">&#160;</span><span class="elsevierStyleBold">Conclusi&#243;n&#58;</span>&#160;El an&#225;lisis farmacocin&#233;tico de la eritropoyetina beta revel&#243; que la semivida de eliminaci&#243;n era significativamente m&#225;s larga en los pacientes con NEB&#44; hallazgo que debe ser confirmado en un estudio bien controlado con una muestra m&#225;s grande&#46;</p>"
      ]
      "en" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Background&#58;</span> Balkan endemic nephropathy &#40;BEN&#41; hemodialysis patients require a higher dose of recombinant human erythropoietin for maintaining target hemoglobin level than patients with other kidney diseases&#46;&#160;<span class="elsevierStyleBold">Objectives&#58; </span>Comparison of the pharmacokinetics of beta-erythropoietin given subcutaneously to hemodialysis patients with BEN or other kidney diseases &#40;non-BEN&#41;&#46;<span class="elsevierStyleBold"> Methods&#58;</span> Recombinant human erythropoietin &#40;75U&#47;kg&#41; was administered subcutaneously to 10 BEN and 14 non-BEN hemodialysis patients&#46; The predose plasma level of erythropoietin &#40;Epo&#41; was subtracted from all postdose levels&#46; The relevant pharmacokinetic parameters were calculated after noncompartmental pharmacokinetic analysis using Kinetica software &#40;Thermo Scientific&#44; ver&#46;5&#46;0&#41;&#46;<span class="elsevierStyleBold"> Results&#58;</span> Although basal plasma Epo concentration was similar in BEN &#40;20&#46;1&#177;10&#46;3U&#47;L&#41; and non-BEN &#40;15&#46;1&#177;8&#46;1U&#47;L&#59; p&#61;&#46;1964&#41; patients&#44; there were significant differences between the groups for elimination rate constant &#40;0&#46;016&#177;0&#46;006 vs 0&#46;026&#177;0&#46;011 hr<span class="elsevierStyleSup">-1</span>&#59; p&#61;&#46;020&#41; and elimination half-life &#40;50&#46;24&#177;19&#46;12 vs 33&#46;79&#177;18&#46;91 hr&#44; p&#61;&#46;048&#41;&#46; These differences remained significant after adjustment for patient characteristics &#40;age&#44; sex&#44; hemodialysis duration&#44; ferritin&#44; PTH and ACEI use&#41;&#46; No significant differences between groups were found in maximal Epo concentration&#44; time to maximum Epo concentration&#44; area under the curve from time of dosing extrapolated to infinity&#44; clearance&#44; mean residence time of Epo between groups both before and after adjustment&#46;<span class="elsevierStyleBold"> Conclusion&#58;</span> Pharmacokinetic analysis of beta-erythropoietin detected a significantly longer elimination half-life in BEN than in non BEN patients&#46; This finding needs to be confirmed in a well-controlled study with a larger sample size&#46;</p>"
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02116995/0000003300000004/v0_201502091404/X0211699513052912/v0_201502091404/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35343"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Especiales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003300000004/v0_201502091404/X0211699513052912/v0_201502091404/es/P1-E557-S4299-A11800.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513052912?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Español
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 10 22 32
2024 Octubre 77 327 404
2024 Septiembre 95 56 151
2024 Agosto 92 78 170
2024 Julio 89 38 127
2024 Junio 114 78 192
2024 Mayo 106 50 156
2024 Abril 98 75 173
2024 Marzo 78 33 111
2024 Febrero 62 39 101
2024 Enero 83 34 117
2023 Diciembre 77 28 105
2023 Noviembre 106 45 151
2023 Octubre 127 40 167
2023 Septiembre 82 44 126
2023 Agosto 103 34 137
2023 Julio 111 36 147
2023 Junio 114 38 152
2023 Mayo 118 50 168
2023 Abril 82 35 117
2023 Marzo 80 33 113
2023 Febrero 60 32 92
2023 Enero 77 26 103
2022 Diciembre 79 32 111
2022 Noviembre 131 41 172
2022 Octubre 95 44 139
2022 Septiembre 113 53 166
2022 Agosto 96 49 145
2022 Julio 85 57 142
2022 Junio 80 47 127
2022 Mayo 88 40 128
2022 Abril 124 65 189
2022 Marzo 94 66 160
2022 Febrero 100 54 154
2022 Enero 80 59 139
2021 Diciembre 88 72 160
2021 Noviembre 137 46 183
2021 Octubre 100 68 168
2021 Septiembre 124 76 200
2021 Agosto 105 52 157
2021 Julio 81 52 133
2021 Junio 97 35 132
2021 Mayo 174 53 227
2021 Abril 232 71 303
2021 Marzo 161 53 214
2021 Febrero 116 35 151
2021 Enero 78 23 101
2020 Diciembre 76 21 97
2020 Noviembre 129 26 155
2020 Octubre 97 17 114
2020 Septiembre 47 11 58
2020 Agosto 55 14 69
2020 Julio 53 7 60
2020 Junio 62 17 79
2020 Mayo 102 23 125
2020 Abril 77 31 108
2020 Marzo 66 15 81
2020 Febrero 86 36 122
2020 Enero 83 25 108
2019 Diciembre 60 22 82
2019 Noviembre 81 26 107
2019 Octubre 86 27 113
2019 Septiembre 52 29 81
2019 Agosto 63 33 96
2019 Julio 65 25 90
2019 Junio 51 5 56
2019 Mayo 85 25 110
2019 Abril 107 35 142
2019 Marzo 59 26 85
2019 Febrero 60 22 82
2019 Enero 28 19 47
2018 Diciembre 97 38 135
2018 Noviembre 169 18 187
2018 Octubre 163 22 185
2018 Septiembre 89 9 98
2018 Agosto 54 17 71
2018 Julio 65 12 77
2018 Junio 74 21 95
2018 Mayo 78 13 91
2018 Abril 100 13 113
2018 Marzo 89 13 102
2018 Febrero 81 9 90
2018 Enero 37 9 46
2017 Diciembre 54 10 64
2017 Noviembre 61 9 70
2017 Octubre 50 10 60
2017 Septiembre 31 11 42
2017 Agosto 46 7 53
2017 Julio 38 10 48
2017 Junio 43 16 59
2017 Mayo 57 9 66
2017 Abril 54 7 61
2017 Marzo 28 6 34
2017 Febrero 23 3 26
2017 Enero 25 2 27
2016 Diciembre 51 6 57
2016 Noviembre 64 11 75
2016 Octubre 93 6 99
2016 Septiembre 118 5 123
2016 Agosto 172 10 182
2016 Julio 174 2 176
2016 Junio 131 0 131
2016 Mayo 188 0 188
2016 Abril 122 0 122
2016 Marzo 120 0 120
2016 Febrero 134 0 134
2016 Enero 122 0 122
2015 Diciembre 151 0 151
2015 Noviembre 131 0 131
2015 Octubre 94 0 94
2015 Septiembre 90 0 90
2015 Agosto 78 0 78
2015 Julio 98 0 98
2015 Junio 47 0 47
2015 Mayo 100 0 100
2015 Abril 31 0 31
2015 Febrero 1382 0 1382
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?